Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 144981 - 145000 out of 493745 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Estonia | (L01ED05) lorlatinib | LORVIQUA õhukese polümeerikattega tablett 25mg N90 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG |
Estonia | (L01EE01) trametinib | MEKINIST tablett 0,5mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited |
Estonia | (L01EE01) trametinib | MEKINIST tablett 2mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited |
Estonia | (L01EF01) palbociclib | IBRANCE õhukese polümeerikattega tablett 100mg N21 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG |
Estonia | (L01EF01) palbociclib | IBRANCE õhukese polümeerikattega tablett 125mg N21 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG |
Estonia | (L01EF01) palbociclib | IBRANCE õhukese polümeerikattega tablett 75mg N21 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG |
Estonia | (L01EG02) everolimus (neoplastic diseases) | AFINITOR tablett 10mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited |
Estonia | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS NORAMEDA tablett 10mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | UABNorameda |
Estonia | (L01EG02) everolimus (neoplastic diseases) | AFINITOR tablett 5mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited |
Estonia | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS NORAMEDA tablett 5mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | UABNorameda |
Estonia | (L01EJ01) ruxolitinib (adm: O) | JAKAVI tablett 10mg N56 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisEuropharmLimited |
Estonia | (L01EJ01) ruxolitinib (adm: O) | JAKAVI tablett 15mg N56 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisEuropharmLimited |
Estonia | (L01EJ01) ruxolitinib (adm: O) | JAKAVI tablett 20mg N56 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisEuropharmLimited |
Estonia | (L01EJ01) ruxolitinib (adm: O) | JAKAVI tablett 5mg N56 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisEuropharmLimited |
Estonia | (L01EK01) axitinib | INLYTA tablett 1mg N56 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerLimited |
Estonia | (L01EL01) ibrutinib | IMBRUVICA tablett 140mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | JANSSEN-CILAGINTERNATIONALNV |
Estonia | (L01EL01) ibrutinib | IMBRUVICA tablett 420mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | JANSSEN-CILAGINTERNATIONALNV |
Estonia | (L01EL01) ibrutinib | IMBRUVICA õhukese polümeerikattega tablett 560mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | JANSSEN-CILAGINTERNATIONALNV |
Estonia | (L01EL02) acalabrutinib | CALQUENCE kõvakapsel 100mg N60 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AstraZenecaAB |
Estonia | (L01EX03) pazopanib | PAZOPANIB ZENTIVA õhukese polümeerikattega tablett 200mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentivak.s. |